NEW YORK (GenomeWeb) – GenePeeks, a computational genomics company focused on disease risk analysis, said today that it has signed an exclusive distribution agreement with India's Core Diagnostics.

Under the agreement, Core Diagnostics will exclusively offer GenePeeks' preconception screen and advanced analytics platform in 29 states and seven union territories in India.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.